No Relevant Pharmacokinetic Drug-Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects.
Yu-Kyong KimJun Gi HwangMin-Kyu ParkPublished in: Drug design, development and therapy (2021)
NCT02854748, Registered on August 7, 2016.
Keyphrases